Industry
Finding New Drugs Is Laborious. This AI Startup Is Skipping The Lab Work
Potential Sciences, a UK government-backed startup, is using AI models trained on computer-generated biochemical data to accelerate drug discovery. The approach aims to bypass traditional lab work, potentially speeding up the development of new drugs. The article highlights the startup's bet on synthetic data to overcome the laborious nature of pharmaceutical R&D.
drug developmentAI in biotechsynthetic data